Evaluation of the Effectiveness of Transforaminal Epidural Injections in Lumbar Disc Herniation or Radiculitis
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To evaluate differences in outcomes in patients receiving steroids compared to those patients randomized to the local anesthetic group who did not receive steroids.
To evaluate and compare the adverse event profile in all patients.
| Condition | Intervention |
|---|---|
|
Low Back Pain |
Drug: lumbar transforaminal epidural injections |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver) Primary Purpose: Treatment |
| Official Title: | A Randomized, Prospective, Double-Blind, Equivalence, Controlled Evaluation of the Effectiveness of Transforaminal Epidural Injections in Lumbar Disc Herniation or Radiculitis With or Without Steroids |
- Numeric rating scale (NRS), Oswestry Disability Index (ODI), duration of significant pain relief, opioid intake, and return to work [ Time Frame: Outcomes are measured at baseline and at 3, 6, 12, 18, and 24 months post-treatment. ] [ Designated as safety issue: Yes ]
- Adverse event profile of side effects and complications. [ Time Frame: Adverse events are measured at baseline and at 3, 6, 12, 18, and 24 months post-treatment, and at any time during the procedure or after the procedure the adverse events are suspected or expected. ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 120 |
| Study Start Date: | February 2010 |
| Estimated Study Completion Date: | January 2014 |
| Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Without Steroids
Group I patients receiving lumbar transforaminal epidural injections with an injection of local anesthetic (lidocaine 1% or bupivacaine 0.25%
|
Drug: lumbar transforaminal epidural injections
with an injection of local anesthetic or with 1% lidocaine or 0.25% bupivacaine with 3 mg of steroid per level
Other Name: 1% Xylocaine, 0.25% bupivacaine, non-particulate Celestone.
|
|
Active Comparator: steroids
Group II patients will receive transforaminal epidural injections with 1% lidocaine or 0.25% bupivacaine with 3 mg of steroid per level
|
Drug: lumbar transforaminal epidural injections
with an injection of local anesthetic or with 1% lidocaine or 0.25% bupivacaine with 3 mg of steroid per level
Other Name: 1% Xylocaine, 0.25% bupivacaine, non-particulate Celestone.
|
Detailed Description:
Recruitment is indicated in patients with chronic low back and lower extremity pain secondary to lumbar disc herniation and/or lumbar radiculitis of at least 6-months duration, non-responsive to conservative management with NSAIDs, physical therapy, chiropractic treatment, and exercises.
This is a single center study performed in an interventional pain management referral center in the United States.
The study involves 120 patients studied in 2 groups with 60 patients in each group. Randomization includes sequence generation, allocation concealment, implementation, and blinding.
Data management analysis includes sample size justification of 40 patients in each group with a power of 80% and a 0.05% 2-sided significance level. Statistical methodology includes chi-squared statistics, Fisher's exact test, t-test, and paired t-test with significance evaluated at P value < 0.05.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
- Patients with disc herniation or radiculitis
- Patients who are 18 years of age
- Patients with a history of chronic function-limiting low back and lower extremity pain of at least 6 months duration
- Patients who are competent to understand the study protocol and provide voluntary, written informed consent and participate in outcome measurements
Exclusion criteria:
- Previous lumbar surgery, radiculitis secondary to spinal stenosis without disc herniation
- Uncontrollable or unstable opioid use
- Uncontrolled psychiatric disorders
- Uncontrolled medical illness either acute or chronic
- Any conditions that could interfere with the interpretation of the outcome assessments
- Pregnant or lactating women
Contacts and Locations| United States, Kentucky | |
| Ambulatory Surgery Center | |
| Paducah, Kentucky, United States, 42001 | |
| Principal Investigator: | Laxmaiah Manchikanti, MD | Ambulatory Surgery Center, Paducah |
More Information
No publications provided
| Responsible Party: | Laxmaiah Manchikanti, MD, Medical Director, Pain Management Center of Paducah |
| ClinicalTrials.gov Identifier: | NCT01052571 History of Changes |
| Other Study ID Numbers: | Protocol 24 |
| Study First Received: | January 18, 2010 |
| Last Updated: | March 21, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Pain Management Center of Paducah:
|
Chronic low back pain Lumbar disc herniation Lower extremity pain Lumbar radiculitis |
Local anesthetic Steroid Lumbar transforaminal epidural injection |
Additional relevant MeSH terms:
|
Back Pain Hernia Low Back Pain Radiculopathy Intervertebral Disk Displacement Pain Neurologic Manifestations Nervous System Diseases Signs and Symptoms Pathological Conditions, Anatomical Peripheral Nervous System Diseases Neuromuscular Diseases Spinal Diseases |
Bone Diseases Musculoskeletal Diseases Anesthetics, Local Bupivacaine Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 21, 2013